WO2003062449A9 - Procedes d'isolement de cellules specifiques de caenorhabditis elegans et d'obtention d'informations genomiques a partir de celles-ci - Google Patents
Procedes d'isolement de cellules specifiques de caenorhabditis elegans et d'obtention d'informations genomiques a partir de celles-ciInfo
- Publication number
- WO2003062449A9 WO2003062449A9 PCT/US2003/001632 US0301632W WO03062449A9 WO 2003062449 A9 WO2003062449 A9 WO 2003062449A9 US 0301632 W US0301632 W US 0301632W WO 03062449 A9 WO03062449 A9 WO 03062449A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- mec
- genes
- elegans
- cell
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 51
- 241000244203 Caenorhabditis elegans Species 0.000 title abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 183
- 230000014509 gene expression Effects 0.000 claims abstract description 47
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 28
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 26
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 26
- 241000244206 Nematoda Species 0.000 claims abstract description 14
- 238000009396 hybridization Methods 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 214
- 101150016833 mec-3 gene Proteins 0.000 claims description 65
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 42
- 101150099501 mec-17 gene Proteins 0.000 claims description 38
- 230000001419 dependent effect Effects 0.000 claims description 23
- 210000002569 neuron Anatomy 0.000 claims description 19
- 108020004414 DNA Proteins 0.000 claims description 18
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 12
- 108700008625 Reporter Genes Proteins 0.000 claims description 11
- 238000000018 DNA microarray Methods 0.000 claims description 10
- 108020004999 messenger RNA Proteins 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 9
- 230000004069 differentiation Effects 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 4
- 210000003036 touch receptor cell Anatomy 0.000 claims description 4
- 108091034117 Oligonucleotide Proteins 0.000 claims description 3
- -1 mec-18 Proteins 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 101100048438 Caenorhabditis elegans unc-30 gene Proteins 0.000 claims description 2
- 101100048446 Caenorhabditis elegans unc-47 gene Proteins 0.000 claims description 2
- 101100316121 Caenorhabditis elegans unc-55 gene Proteins 0.000 claims description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 claims description 2
- 230000009368 gene silencing by RNA Effects 0.000 claims description 2
- 101150096625 unc-4 gene Proteins 0.000 claims description 2
- 108091033319 polynucleotide Proteins 0.000 claims 6
- 102000040430 polynucleotide Human genes 0.000 claims 6
- 239000002157 polynucleotide Substances 0.000 claims 6
- 230000001404 mediated effect Effects 0.000 claims 4
- 230000002018 overexpression Effects 0.000 claims 2
- 238000002123 RNA extraction Methods 0.000 claims 1
- 239000000074 antisense oligonucleotide Substances 0.000 claims 1
- 238000012230 antisense oligonucleotides Methods 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 28
- 210000002257 embryonic structure Anatomy 0.000 description 27
- 241001465754 Metazoa Species 0.000 description 20
- 239000005090 green fluorescent protein Substances 0.000 description 18
- 239000000872 buffer Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000003321 amplification Effects 0.000 description 9
- 230000027455 binding Effects 0.000 description 9
- 235000013601 eggs Nutrition 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- 101100539485 Caenorhabditis elegans unc-86 gene Proteins 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 8
- 101150012912 mec-7 gene Proteins 0.000 description 8
- 101100536577 Caenorhabditis elegans cct-4 gene Proteins 0.000 description 7
- 241000282412 Homo Species 0.000 description 7
- 239000008188 pellet Substances 0.000 description 7
- 238000003757 reverse transcription PCR Methods 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 108050001186 Chaperonin Cpn60 Proteins 0.000 description 6
- 102000052603 Chaperonins Human genes 0.000 description 6
- 108091035707 Consensus sequence Proteins 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 101150079143 mec-4 gene Proteins 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 101100152636 Caenorhabditis elegans cct-2 gene Proteins 0.000 description 5
- 101100456536 Caenorhabditis elegans mec-2 gene Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 101150058217 mec-10 gene Proteins 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 102000029749 Microtubule Human genes 0.000 description 4
- 108091022875 Microtubule Proteins 0.000 description 4
- 238000011530 RNeasy Mini Kit Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 102000004243 Tubulin Human genes 0.000 description 4
- 108090000704 Tubulin Proteins 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 101150019229 dpy-20 gene Proteins 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 210000004688 microtubule Anatomy 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 229960005322 streptomycin Drugs 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 3
- 241001156002 Anthonomus pomorum Species 0.000 description 3
- 241000244201 Caenorhabditis briggsae Species 0.000 description 3
- 101100260051 Caenorhabditis elegans cct-1 gene Proteins 0.000 description 3
- 101100424627 Caenorhabditis elegans mec-12 gene Proteins 0.000 description 3
- 102000012286 Chitinases Human genes 0.000 description 3
- 108010022172 Chitinases Proteins 0.000 description 3
- 244000183685 Citrus aurantium Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102000018697 Membrane Proteins Human genes 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 108010000605 Ribosomal Proteins Proteins 0.000 description 3
- 102000002278 Ribosomal Proteins Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 101710137500 T7 RNA polymerase Proteins 0.000 description 3
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 101710159648 Uncharacterized protein Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 230000010196 hermaphroditism Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- 108020003589 5' Untranslated Regions Proteins 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010009685 Cholinergic Receptors Proteins 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 102000005915 GABA Receptors Human genes 0.000 description 2
- 108010005551 GABA Receptors Proteins 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 241000221931 Hypomyces rosellus Species 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- 241000243985 Onchocerca volvulus Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- 102000004257 Potassium Channel Human genes 0.000 description 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 102000034337 acetylcholine receptors Human genes 0.000 description 2
- 230000010455 autoregulation Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000036815 beta tubulin Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000011712 cell development Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 210000002241 neurite Anatomy 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 108020001213 potassium channel Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000003196 serial analysis of gene expression Methods 0.000 description 2
- 239000003001 serine protease inhibitor Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000000392 somatic effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- YUXKOWPNKJSTPQ-AXWWPMSFSA-N (2s,3r)-2-amino-3-hydroxybutanoic acid;(2s)-2-amino-3-hydroxypropanoic acid Chemical compound OC[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O YUXKOWPNKJSTPQ-AXWWPMSFSA-N 0.000 description 1
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 102100025230 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial Human genes 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- 101150055869 25 gene Proteins 0.000 description 1
- 102100037685 60S ribosomal protein L22 Human genes 0.000 description 1
- 101710187788 60S ribosomal protein L22 Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102100035785 Acyl-CoA-binding protein Human genes 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 108010087522 Aeromonas hydrophilia lipase-acyltransferase Proteins 0.000 description 1
- 102000018518 Aldehyde dehydrogenase domains Human genes 0.000 description 1
- 108050007629 Aldehyde dehydrogenase domains Proteins 0.000 description 1
- 102100021954 Alpha-tubulin N-acetyltransferase 1 Human genes 0.000 description 1
- 101100452755 Arabidopsis thaliana I-2 gene Proteins 0.000 description 1
- 101150033765 BAG1 gene Proteins 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100441885 Caenorhabditis elegans cyn-5 gene Proteins 0.000 description 1
- 101100528916 Caenorhabditis elegans rol-6 gene Proteins 0.000 description 1
- 101100035113 Caenorhabditis elegans rpl-17 gene Proteins 0.000 description 1
- 101100469866 Caenorhabditis elegans rpl-20 gene Proteins 0.000 description 1
- 101100201838 Caenorhabditis elegans rsp-6 gene Proteins 0.000 description 1
- 101100310928 Caenorhabditis elegans sra-6 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102000007345 Chromogranins Human genes 0.000 description 1
- 108010007718 Chromogranins Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108010033806 Degenerin Sodium Channels Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 108010039287 Diazepam Binding Inhibitor Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 239000004243 E-number Substances 0.000 description 1
- 235000019227 E-number Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102100040553 FXYD domain-containing ion transport regulator 3 Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 101710103773 Histone H2B Proteins 0.000 description 1
- 102100021639 Histone H2B type 1-K Human genes 0.000 description 1
- 102000009331 Homeodomain Proteins Human genes 0.000 description 1
- 108010048671 Homeodomain Proteins Proteins 0.000 description 1
- 101000753184 Homo sapiens Alpha-tubulin N-acetyltransferase 1 Proteins 0.000 description 1
- 101000893731 Homo sapiens FXYD domain-containing ion transport regulator 3 Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 102100021496 Insulin-degrading enzyme Human genes 0.000 description 1
- 108090000828 Insulysin Proteins 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- 108010085747 Methylmalonyl-CoA Decarboxylase Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- 108700035706 Non-specific lipid-transfer protein-like Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101150025079 RPS14 gene Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 102000003926 Ribosomal protein L18 Human genes 0.000 description 1
- 108090000343 Ribosomal protein L18 Proteins 0.000 description 1
- 102000010983 Ribosomal protein S13 Human genes 0.000 description 1
- 108050001197 Ribosomal protein S13 Proteins 0.000 description 1
- 101150034081 Rpl18 gene Proteins 0.000 description 1
- 102000000395 SH3 domains Human genes 0.000 description 1
- 108050008861 SH3 domains Proteins 0.000 description 1
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- 102000008847 Serpin Human genes 0.000 description 1
- 108050000761 Serpin Proteins 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 102100021685 Stomatin Human genes 0.000 description 1
- 108700037714 Stomatin Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 108091061763 Triple-stranded DNA Proteins 0.000 description 1
- 101000956368 Trittame loki CRISP/Allergen/PR-1 Proteins 0.000 description 1
- 102000012275 Ubiquitin domains Human genes 0.000 description 1
- 108050002897 Ubiquitin domains Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047697 Volvulus Diseases 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 101150010487 are gene Proteins 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 108091005948 blue fluorescent proteins Proteins 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 108020001778 catalytic domains Proteins 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000023715 cellular developmental process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000001819 effect on gene Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002308 embryonic cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 201000007647 intestinal volvulus Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 108060004734 metallo-beta-lactamase Proteins 0.000 description 1
- 102000020235 metallo-beta-lactamase Human genes 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 238000003499 nucleic acid array Methods 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000003133 propidium iodide exclusion Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 230000025220 protein targeting to vacuole Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 102000004314 ribosomal protein S14 Human genes 0.000 description 1
- 108090000850 ribosomal protein S14 Proteins 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- ATCJTYORYKLVIA-SRXJVYAUSA-N vamp regimen Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1.C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C(C45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 ATCJTYORYKLVIA-SRXJVYAUSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
Definitions
- the present invention relates to methods of separating one or more particular cell types from the nematode Caenorhabditis elegans, as well as to methods for identifying cell type specific genes therefrom, and analyzing the identified gene sequences to retrieve cell type specific expression elements.
- C. elegans develops from a single, fertilized cell into an adult animal having complex tissues and organ systems.
- a substantial proportion of the cells (302 of the 959 somatic nuclei of the adult hermaphrodite worm) constitute a nervous system that can detect odor, taste, and respond to temperature and touch. Because the animal is virtually transparent, its bodily events can be observed under a microscope.
- C. elegans carries out many of the same processes that humans do, including embryonic development, digestion, reproduction, and senescence, and, as such they are "particularly useful for studying early development, neurobiology, and aging” (Id.). "In fact, every connection in the worm's nervous system has been mapped, and the lineage of each cell in the adult animal's body has been tracked from the moment of fertilization" (Id.).
- the C. elegans genome contains 19,099 protein-coding genes - about one every 5,000 DNA bases - and 800 or so genes that have other functions, several times the number of genes predicted by classical genetics experiments, approximately 40 percent of which match those of other organisms, including humans (http ⁇ /w ⁇ vw.nhgri.nih.gov/NEWS/Worm/ ⁇ wpr ⁇ ).
- Nematodes are important pathogens of plants and humans, creating substantial agricultural and medical problems.
- Currently available nematicides tend to be environmentally and physiologically toxic. It is therefore desirable to develop safer nematode control strategies through a better understanding of nematode molecular biology.
- the present invention relates to methods for isolating specific types of cells from the nematode Caenorhabditis elegans, isolating RNA therefrom and amplifying the collected RNA to produce amplified nucleic acid, exposing the amplified nucleic acid, under hybridization conditions, to a collection of reference nucleic acids representative of a plurality of nematode genes, and identifying the particular reference nucleic acids which hybridize.
- the reference nucleic acids that hybridize more strongly, particularly those that exhibit greater hybridization relative to control hybridization levels obtained using nucleic acid collected from other C. elegans cells or the general population of C elegans cells may represent genes that are selectively expressed in the specific cell type isolated.
- the nucleic acid sequences of the flanking regions of the cell type specific genes isolated may be analyzed to identify cell type specific expression elements.
- the present invention is based, at least in part, on the discovery that touch receptor neurons of C. elegans could be isolated by engineering the general cell population to contain a nucleic acid construct comprised of a detectable gene product (in the example provided, Green Fluorescent Protein) operably linked to a touch cell-specific promoter and then sorting dissociated cells of the general population based on the presence or absence of the detectable gene product (in the working example, using fluorescence-activated cell sorting). Additional specificity could be obtained by further sorting the cells by other characteristics, such as by size and/or viability.
- a detectable gene product in the example provided, Green Fluorescent Protein
- the methods of the invention provide a means for identifying and isolating genes that are expressed at low levels in the general cell population of C. elegans, but at higher levels in specific cell types. Analysis of RNA collected from whole organisms may fail to identify such genes. Accordingly, the present invention provides the capability of identifying genes present in specific cell types which previously would have been virtually unretrievable using present technology. The genes recovered may then be used to identify cell type specific elements. The cell type specific genes identified may then be used to produce model systems of physiologically important functions. The working examples provided here show that genes associated with touch sensitivity were identified. Some of these genes have been found to be associated into ion channels that are responsive to agents that have physiologic activity in humans.
- the methods of the invention may be used to produce screening systems for human drug development.
- the usefulness of C. elegans as a screening system for biologically active agents relevant to either pest control in agriculture or human medicine is well known; the present invention provides a substantial enhancement of the specificity of such screening systems .
- Figure 1 A wild-type touch receptor neuron and a mec-3 mutant cell after 12 hours in culture. Both cells fluoresce because of expressed GFP.
- the wild-type cell has a single neurite, whereas the mec-3 cell has several shorter neurites.
- FIG. 1 Northern analyses of amplified RNA from sorted wild-type touch cells (WI and W2), sorted mec-3 mutant cells (Ml and M2), and unsorted wild-type cells (U). Samples were probed with cDNAs for the indicated genes.
- FIG. 3A-B The MEC-3 ::UNC-86 binding site.
- A The consensus sequence derived from known MEC-3 ::UNC-86 binding sites from the mec-3, mec-4 and mec-7 genes in C. elegans, C. briggsae and C. vulgaris. The sequence is displayed from 5' to 3'; a perfect match would have a score of two bits.
- B Positions of significant matches (P ⁇ 10 "4 ) to the consensus sequence in the 5' UTRs of newly identified and known mec- 3-dependent genes. The position of the start ATG is taken as 0; the heights of the bars are proportional to the extent the identified sites match the consensus sequence. The bars under the lines represent the sequences in the other strand.
- FIG. 4A-F Examples of newly identified r ⁇ .ec-3-dependent genes.
- SEQ LD NO:l ClustalW alignment of MEC-17 (F57H12.7) (SEQ LD NO:l) and similar proteins: W06B11.1 (SEQ TD NO:2) from C. elegans, CG3967 (SEQ LD NO:3) and CG17003 (SEQ TD NO:4) from D. melanogaster, BAB29231 (SEQ ID NO:5) and BAB22194 (SEQ ID NO:6) from mice, and FLJ13158 (SEQ ID NO:7) and BAB14472 (SEQ ID NO:8) from humans (BAB names are GenBank accession numbers; others are gene names). Amino acids identical (red) or similar (blue) to those in MEC-17 are indicated.
- the amino acids identical (red) or similar (blue) to those in MEC-17 are indicated.
- nucleotide changes for the mutations are CTT (L) -> TTT (F) and GAT (D) - GGT
- FIG. 5A-C Purification of C. elegans neurons by fluorescence-activated cell sorting (FACS). Representative flow cytometric data used for purifying GFP-positive neurons. Data collected on 100,000 total events employing a fluorescence threshold trigger on the cell sorter. All parameters measured using logarithmic signal processing electronics.
- FACS fluorescence-activated cell sorting
- Representative flow cytometric data used for purifying GFP-positive neurons. Data collected on 100,000 total events employing a fluorescence threshold trigger on the cell sorter. All parameters measured using logarithmic signal processing electronics.
- A Forward Scatter laser light (cell size) versus propidium iodide fluorescence used to select viable cells as determined by propidium iodide exclusion.
- B Green (515-545 mn) versus orange (564-586 nm) fluorescence distribution gated on viable cells was used to select GFP positive cells.
- C Light scatter distribution of GFP-positive neurons showing heterogeneity of cell size and morphology.
- GFP-positive neurons are enriched 100 fold by fluorescence-activated cell sorting.
- the present invention provides for methods for isolating specific cell types of C. elegans or other nematodes.
- Cell types which may be isolated in this manner include muscle, skin, gut, excretory, germ line, and somatic gonad cells and 118 classes of neurons (see White et ah, 1986, Proc. Roy. Acad. Sci. 314:1-340).
- a preferred nonlimiting embodiment, in which touch receptor cells are isolated, is set forth in the examples that follow.
- a construct which is selectively expressed in the cells which are to be isolated.
- a construct comprises a reporter gene which encodes a detectable gene product operably linked to a promoter which is specifically active in the cell type to be isolated.
- suitable reporter genes include those encoding green, blue, yellow or red fluorescent proteins, ⁇ -galactosidase, ⁇ -glucuronidase, luciferase , or other proteins whose presence are visibly discernible in viable cells, of which green fluorescent protein is most preferred.
- the reporter gene under the control of the cell type-specific promoter may encode a surface protein whose presence on the cell may be detected through the specific binding of an antibody or ligand.
- the reporter gene under the control of the cell type- specific promoter may encode a protein that confers resistance to an antibiotic or other substance that induces cell death or apoptosis in cells lacking the expression of the protein.
- the promoter selected be completely cell type specific.
- a promoter expressed selectively, but not exclusively, in a cell type having a large size may be used in conjunction with a procedure that selects for larger cells.
- Non- limiting examples of suitable promoters include, but are not limited to, the mec-3 and mec-18 promoters (specific for touch receptor cells), the unc-4, unc-30, unc-55, unc-25, unc-47 and ttx-1 promoters, all of which are nerve cell specific.
- the construct may be incorporated into the intact organism, as set forth in the examples below, or may be incorporated after the organism is dissociated into individual cells using standard techniques.
- organisms comprising the reporter construct are propagated to late stage embryos, which are then dissociated and sorted.
- dissociated cells are then subjected to a sorting method which identifies the reporter gene product.
- fluorescence-activated cell sorting methods may be used.
- affinity-based methods known to those of ordinary skill in the art also may be employed to isolate the cells expressing the reporter gene encoding a protein expressed on the cell surface from those that lack expression of this same protein.
- cell populations that specifically express a surface protein may be isolated using fluorescence-activated cell sorting if the antibody or ligand that specifically binds to the cell surface protein is conjugated to a fluorescent tag, a wide variety of which are known to the practitioner of ordinary skill in the art of cell sorting. Additional means of sorting, such as by size, viability or resistance to the otherwise toxic effects of certain exogenous substances, may also be performed.
- the cells may be cultured prior to selection. In this way, substantial numbers of cells may be made available for sorting, providing a large source of RNA, an advantage over the prior art. Non-terminally differentiated cells may be further cultured after sorting.
- the isolated cells may then be used to prepare cell type-specific RNA.
- the resulting RNA may then be used directly as a probe, or may be amplified into RNA or DNA.
- the nucleic acid to be used as a probe is detectably labeled.
- Cell type-specific nucleic acid prepared as above, may then be used to screen a plurality of genes from C. elegans and/or other organisms.
- arrays such as dot blot arrays or, more preferably, microchip-based nucleic acid arrays may be used.
- control screening is performed using, as probe, nucleic acid generated from a reference population of C. elegans cells.
- gene screening techniques well known to those of ordinary skill in the art may be useful in establishing the identity of novel genes present in the cell types isolated by the procedures described herein.
- nucleic acids such techniques may include, but are not limited to SAGE (serial analysis of gene expression) or the screening of candidate genes by RT-PCR.
- Protein chips may also be used to identify genes expressed specifically in the isolated cell populations either by simply applying to the chip a protein mixture obtained from the specific cell population isolated using the procedures described herein or by first translating in vitro the RNA isolated from the specific cell population and analyzing the proteins so obtained by means of mass spectroscopy, protein microarrays, or other techniques known to those of ordinary skill in the art that are suitable for protein identification.
- Genes identified as being cell type-specific then may be analyzed to identify cell type-specific expression elements which then may be subjected to further study and use in model systems.
- the present invention further provides wild-type and mutant nucleic acid and amino acid sequences for the C. elegans mec-5-dependent gene mec-17. Because mec-17 is important for maintenance of the differentiated state in C. elegans suppression of mec-17 gene expression by antisense or RNA interference methods known to those of ordinary skill in the art may be used for maintaining C. elegans cells in a non- differentiated state. Alternatively, forced expression of mec-17 through the introduction into target cells of vectors expressing the mec-17 gene may be used for triggering the terminal differentiation of C. elegans cells. Thus, the present invention provides methods for modulating the differentiation of C. elegans cells by modulation of mec-17 expression.
- vectors useful for the introduction of nucleic acids that modulate cellular mec-17 gene expression include, but are not limited to, plasmids, cosmids, artificial chromosomes, or virus-based vectors known to be capable of introducing genetic material into C. elegans cells. Such vectors would be readily apparent to those of ordinary skill in the art.
- RNA from whole animals with and without particular cell types like the six touch receptor neurons
- DNA microarrays has an inherent sensitivity problem. Low abundance RNAs expressed in only a few cells or differences in RNA expression in particular cells are difficult to detect. Indeed, no touch cell genes were identified using RNA from wild- type and mec-3 mutant animals on DNA microarrays. This limitation was circumvented by obtaining and culturing wild-type and mec-3 mutant cells from embryos, isolating touch cells by cell sorting, and amplifying RNA from the isolated cells.
- the isolated cells were identified by GFP fluorescence, expressed from the promoter for the touch cell-specific gene mec-18 for wild-type cells (the embryos have four touch cells: ALMLR and PLML/R) or the mec-3 promoter, which is expressed in the touch cells and two other neurons (FLPL/R) in the embryos (Way and Chalfie, 1989, Genes Dev. 3:1823-33), for mec-3 mutant cells. Both promoters are expressed after the touch cells are generated. The dissociated embryos yielded a very small number of faintly fluorescent cells. When cultured overnight, however, more cells (0.3-0.6%) elaborated processes and had intense GFP fluorescence.
- GFP-positive cells which were presumably generated and/or differentiated in culture, were remarkably like in vivo touch receptor neurons in morphology (FIGURE 1) and gene expression (FIGURE 2; Table 1).
- the wild-type cultured cells were usually monopolar with a single, long process or bipolar with a smaller second process 180° from the first, i.e., similar to the in vivo ALM and PLM cells, respectively.
- the mec-3 cells were bipolar or multipolar with smaller processes that branched more randomly. This morphology is similar to that seen in vivo (Chalfie and Sulston, 1981, Dev Biol 82:358-70; Way and Chalfie, 1989, Genes Dev. 3:1823-33).
- RNA from sorted wild-type cells and mec-3 cells was hybridized to genomic DNA microarrays containing DNA for 17,817 of the 18,967 known or predicted C elegans genes (Jiang et al, 2001, Proc Nail Acad Sci USA 98:218-23) to identify genes that were r ⁇ ec-3-dependent.
- Three sets of independently prepared RNA samples from mutant and wild type touch cells were each hybridized onto two separate arrays. Seventy-one r ⁇ ec-3-dependent candidate genes were identified by choosing genes
- genes could be either mec-3 repressed genes or genes that are expressed in a mec-3 -independent manner in the FLP cells. Gene expression was also compared in sorted mec-3 mutant cells and unsorted wild-type cells and identified 722 candidate genes that were enriched in the mec-3 mutant cells.
- the arrays were spotted with coding-rich sequences from genomic DNA, and the DNAs for these three genes would not hybridize to at least 600 nt at the 3' ends of the RNAs.
- the amplification methods employed preferentially produce sequences from the 3' ends of the RNAs.
- DNA microarrays capable of detecting the 3' ends of mRNAs would have more accurately identified the mec-3-dependent genes.
- RNAs from wild type and mutant cells All of these genes ranked below mec-3. As described below for the cct genes, genes giving small ratios can be differentially expressed in the touch cells. The modest difference in expression may result from more general gene expression or an indirect effect on gene expression resulting from the differentiation of the wild type cells. Altogether two of the 22 tested genes that were not previously known to depend on mec-3 had differential
- MEC-3 maintains its own transcription and activates the mec-4 and mec-7 genes as part of a MEC-3 ::UNC-86 heterodimer (Xue et al, 1992, EMBO J 11:4969-79; Xue et al, 1993, Science 261:1324-8; Duggan et al, 1998, Development 125:4107-19).
- the motif-finding program MEME (Bailey and Elkan, 1994, Proc Int Conflntell Syst Mol Biol 2:28-36) was used to define a consensus (FIGURE 3A) for these binding sites from these genes in C. elegans and two related nematodes C. briggsae and C. vulgaris.
- oligonucleotide frequencies (Van Helden et al, 2000, Yeast 16:177-87) in the top twenty genes in Table 1 were also examined, and these studies identified a single heptanucleotide (AATGCAT) that was significantly overrepresented (P ⁇ 0.01). This motif matches the UNC-86 binding core in the consensus sequence (FIGURE 3A), and, thus provides a proof-of-principle that such binding sites can be deduced from the array data. Twenty-eight of the 71 genes in Table 1 have this heptanucleotide. Consistent with the hypothesis that genes showing strong enrichment are direct targets of mec-3 regulation, 13 of the 16 genes with expression ratios from real time RT-PCR
- the genes reflect the general distribution of genes on all six chromosomes. Most mec-3-dependent genes are found in the gene clusters on the autosorn.es, but some are also found near the ends of the chromosomes. The genes are also fairly uniformly distributed on the X chromosome, which has no cluster. In general, the six touch receptors do not use genes from specific parts of the chromosomes.
- Table 1 contains unc-24, whose product shares a stomatin-like region with MEC-2 (Barnes et al, 1996, J Neurochem 67:46-57) and acr-13, an acetylcholine receptor subunit (two other such subunits are expressed in the touch cells (Treinin and Chalfie, 1995, Neuron 14:871-7; Treinin et al, 1998, Proc Natl Acad Sci USA 95: 15492-5) but are not included in Table 1).
- Table 1 may well contain genes providing functional redundancy, but redundancy through the use of multiple members of gene families does not seem to play a numerically important role in touch cell differentiation.
- the touch receptor neurons have a distinctive morphology and are not found as yet in non-nematode species, the genes used by these cells are not more nematode-specific than those of the entire C. elegans genome. Thirty-eight percent (27/71) of the genes in Table 1 are similar to genes in other organisms, compared with 36% for all C. elegans genes (Rubin et al, 2000, Science 287:2204-15).
- Table 1 provides a large number of genes to test for their effects on the development and function of the touch cells.
- the highest-ranking gene in Table 1, F57H12.7 is an example of such a gene.
- F57H12.7 maps to the same position of the previously uncloned mec-17 gene, mec-17 appears to be needed for the maintained differentiation of the touch cells; mec-17 mutants are touch sensitive at hatching, but become insensitive as they mature (Chalfie and Au, 1989, Science 243:1027-33 (1989). Expression of mec-3 and mec-7 is reduced in older mec-17 animals (Way and Chalfie, 1989, Genes Dev.
- F57H12.7 was identified as mec-17 because the single mutant allele of mec-17, u265, contained two missense mutations (FIGURE 4A) and microinjection of F57H12.7 genomic DNA into mec-17 (u265) animals rescued the mutant phenotype.
- F57H12.7 is expressed solely in the touch cells; as the GFP fusion protein was very strongly expressed in these cells from late embryos to adults (FIGURE 4B). This expression depends on mec-3, since no fluorescence was seen when the fusion was expressed in mec-3 mutants.
- mec-17 encodes a predicted polypeptide of 262 amino acids. Because the protein is novel with no readily identifiable motifs, the sequence does not provide any hints as to how mec-17 may act to maintain the expression of mec-3 and the differentiation of the touch cells. Nonetheless, mec-17, the one other predicted C. elegans gene, W06B11.1, and two predicted genes each from Drosophila, mouse and humans share a 158 amino acid domain with 29-41% identity (FIGURE 4A). This shared domain suggests that these proteins may function similarly.
- genes in Table 1 especially those with strong mec-3- dependent expression present interesting questions about their roles in the function of these cells.
- Such genes include twk-28 (encoding a TASK potassium channel protein), ZC482.5 (GABA receptor subunit), four genes encoding predicted enzymes or proteins with catalytic domains [C03A3.3 (metallo- ⁇ -lactamase), F14E5.4 (acid phosphatase), and F20D6.5 (tyrosine kinase), and F01D5.8 (esterase)], two genes (C06A8.3 and far-3) encoding proteins similar to antigens from the parasitic nematode Onchocerca volvulus, and four genes (rpl-20, rps-18, rps-18 and rps-14) encoding ribosomal proteins.
- the last set of genes, the cct genes, and perhaps others may be enriched in the wild-type touch cells as a secondary consequence of the activation of other genes (e.
- RNA from whole animals has been applied to DNA microarrays to see gross differences in expression between the male and hermaphrodite animals (Jiang et al, 2001, Proc Natl Acad Sci USA 98:218-23) or germ lines (Reinke et al, 2000, Mol Cell 6:605-16), which make up approximately two thirds of the cells in adults, or between animals at different developmental stages (Hill et al, 2000, Science 290:809-12; Jiang et al, 2001, Proc Natl Acad Sci USA 98:218-23).
- DNA microarrays can be used to identify potential differentiation targets for single types of cells in multicellular organisms and these techniques should be applicable toward the study of cellular development and function under a variety of experimental conditions.
- RNA from the sorted cells was amplified through two rounds by a modification of the method of Eberwine et al. (Eberwine et al, Proc Natl Acad Sci USA 89:3010-4). Real time RT-PCR. Approximately 3-5 ⁇ g of second round amplified RNA from either purified wild type or mec-3 (el 338) touch cells was converted to cDNA using random primers and PowerScript reverse transcriptase (Clontech) according to the manufacturer's protocol.
- RNA samples were generated from 3 independent primary cell cultures and cell sortings for wild-type touch cells (wl, w2 and w3) and for mec-3(el338) touch cells (ml, m2 and m3).
- Each hybridization (wl-ml, w2-m2, w3-m3) was done twice. All non-flagged spots for which the net fluorescence intensity at least in one channel was three background standard deviations above background were considered well hybridized and measured. If the net fluorescence intensity for a non-flagged spot was within one standard deviation of the background, net fluorescence intensity was set as one standard deviation of the background. The natural logs of the ratios for the duplicate hybridizations were averaged. T-test P values were determined with the averages from three independent experiments.
- the motif-finding program MEME (Bailey and Elkan, 1994, Proc Int Conf Intell Syst Mol Biol 2:28-36; meme.sdsc.edu/meme/website/meme.html) was used to derive a 19 nucleotide consensus sequence from 19 known MEC-3 ::UNC-86 binding sites in the promoter region of mec-3, mec-4 and mec-7 in C.elegans, C. briggsae, and C. vulgaris.
- a weight matrix for the defined consensus site was built based on the multiple sequence alignment and was used to search the 5' UTRs of the genes in Table 1 for the significant matches (P ⁇ 10 "4 ) using the pattern search tool at www.ucmb.ulb.ac.be/bioinformatics/rsa-tools/.
- a graphical representation of the weight matrix was generated using the tool available at ep.ebi.ac.uk/EP/SEQLOGO/.
- Protein-protein blast (BlastP) (www.ncbi.nlm.nih. gov/BLAST with the non- redundant protein data base at NCBI and with C. elegans proteins at Wormbase ( " www.wormbase.org) was used to identify similar genes, i.e. those with an expectation value (E) ⁇ 10 ⁇ 10 and that are aligned through at least 80% of their lengths as in Chervitz et al. (Chervitz et al, 1998, Science 282:2022-8).
- the mec-17(u265) genomic fragment was amplified by PCR from worm lysates.
- the PCR product was sequenced by GeneWiz Inc., New York.
- a 5.5 kb fragment of mec- 17 genomic DNA was amplified by PCR using the Clontech polymerase mixture and
- the plasmid (0.75 ng/ ⁇ l) was injected with the rol-6(sul006) marker plasmid ⁇ RF4 (Mello et al, 1991, EMBO J
- mec-17::gfp was generated by inserting about 5 kb genomic DNA fragment (produced by PCR) including 1.9 kb upstream sequence and all the predicted genomic sequence except for the 42 amino acids at the C-terminus of MEC-17 into pPD95.77 (a gift from A. Fire), which contains the gfp gene with added introns.
- the construct was transformed with DA#735 (Huang et al, 1994, Mol Biol Cell 5:395-411), a plasmid containing lin-15(+) DNA, into MT1642 [Un-15(n765J ⁇ .
- Transgenic worms from three stable lines were examined using an Axiophot microscope with an FITC filter set.
- the cct-4::gfp construct was generated by inserting 2389 bases of cct-4 genomic DNA including 585 bases of upstream sequence in frame into pPD95.77.
- PcctX 'gfp was generated by inserting 2436 bases of upstream sequence of cct-2 and 42 base of coding sequence in frame into pPD95.77.
- the construct and pMH86 were injected into TU353.
- Hermaphrodites with extrachromosomal arrays from three stable lines were mated with dpy-20(el282) males to obtain touch sensitive mec-3/+ heterozygotes that were examined for fluorescence.
- Y48G8AL.8 Contains ribosomal protein L22 signature 3.13 0.032 cct-1 T-complex chaperonin protein 2.10 0.002 4 mec-3 LI homeodomain transcription factor 3.09 0.014 7 C02F5.3 GTP-binding protein 2.10 0.047 rpl-18 Ribosomal protein L18 3.05 0.047 R05D7.5 Unknown 2.09 0.038
- C Isolation of cells from the embryos. Divide the staged embryos between two 50 ml conical tubes, wash embryos IX with 25 ml egg buffer (D3), and remove as much of the buffer as possible. Resuspend the embryos in 2 volumes (usually 20 ml per tube) of chitinase/chymotrypsm solution (D4) and gently shake at room temperature. Monitor the embryos by DIG to determine that the eggshells have been digested (usually 5 min - extended treatment damages the cells). Wash the embryos with egg buffer and pellet them at 2,000 rpm for 1 min.
- D3 chitinase/chymotrypsm solution
- Concentrated OP50 Culture OP50 (Brenner, 1994, Genetics 77:71-94) overnight at 37°C in 12 L of Superbroth (Sambrook et al, 1989, Molecular Cloning: A Laboratory Manual, 2 nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), pellet, and resuspend in 60 ml of M9 buffer (final volume approximately 120 ml). Store at 4°C until needed.
- Hypochlorite solution 1 ml sodium hypochlorite (Sigma), 2.5 ml 1 M NaOH, 1.5 ml dH 2 O.
- Egg buffer 11.8 ml 1 M NaCl, 4.8 ml 1 M KC1, 0.34 ml 1 M CaCl 2 , 0.34 ml 1 M MgCl 2 , 2.0 ml 0.25 M HEPES (pH 7.4), 82.5 ml dH 2 O. Filter-sterilize and store at
- Chitinase/chymotrypsin 5 mg chitinase (Sigma C-6137), 5 mg alpha- chymotrypsin (ICN 152272), 1 ml egg buffer, 10 ⁇ l penicillin-streptomycin [Cat. No. 15140-148, 10,000 units of Penicillin (base) and 10,000 ⁇ g of Streptomycin base/ml, Gibco] . Freeze in 10 ml aliquots at -20°C.
- L-15CM 24 ml L-15 (Gibco), 6 ml inulin [ICN 102055; 7.5 mg/ml egg salts (D7), autoclaved and stored at 4°C], 0.4 ml base mix (D8), 200 mg PVP (polyvinylpyrrolidone, Sigma), 0.4 ml penicillin-streptomycin (Gibco). Filter- sterilize, add 8 ml fetal bovine serum (Heat-inactivated, Sigma), and store at 4°C until needed on the same day.
- L-15SFM 24 ml L-15, 6 ml inulin, 0.4 ml base mix, 10 ml egg buffer, 0.4 ml penicillin-streptomycin, 100 mg PNP. Filter-sterilize and store at 4°C. 7.
- TESPA-coated slides Soak microscopic slides in 70% ethanol and 1% HI for 1 to 2 hours. Rinse 3X with dH2o Air-dry and sterilize slides under a culture hood UN lamp for 1 hr (all subsequent steps should be performed under sterile conditions). Soak slide in 4% TESPA (3-aminopropyltriethoxysilane, Sigma)/acetone solution for 5 min. Wash slides in acetone twice. Air dry. Soak slides in 4% paraformaldhyde/PBS solution for 30 min at room temperature. Wash slides in sterile water for four times. Air dry and store at room temperature. Treated slides have to be used within 3 days.
- Base mix 100 ml H 2 O, 100 mg adenine, 10 mg ATP, 3 mg guanine, 3 mg hypoxanthine, 3 mg thymine, 3 mg xanthine, 3 mg uridine, 5 mg ribose, 5 mg deoxyribose; autoclave and store at 4°C.
- Enrichment cell sorting used a fluorescence threshold trigger (FLTT) instead of the standard light scatter threshold trigger (LSTT) (McCoy et al, 1991, Cytometry 12:268-74). This technique helps reduce the analysis of small particles and negative cells and allows for higher throughput of cell suspensions from disassociated embryos.
- FLTT fluorescence threshold trigger
- LSTT standard light scatter threshold trigger
- RNA quality decreases, however, with the extended storage.
- 8 ⁇ l of the reaction can be mixed in another tube with 0.8 ⁇ l ⁇ -P 32 -CTP. Incubate both tubes at 37°C for 18 hours. Purify transcripts from cold reaction using the RNeasy Minikit. Precipitate the hot reaction with 5% trichloroacetic acid and 20 niM sodium pyrophosphate to determine the amount of transcription (Sambrook et al, 1989, Molecular Cloning: A Laboratory Manual, 2 n edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
- 5X second stranded buffer 500 mM KCl, 50 mM (NH 4 ) 2 SO 4 , 25 mM MgCl 2, 0.75 mM NAD + (nicotinamide adenine dinucleotide), 100 mM Tris-Cl (pH 7.5), and 0.25 mg/ml BSA.
- 10X KFI buffer 200 mM Tris (pH 7.5), 100 mM MgCl 2 , 50mM NaCl.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003205235A AU2003205235A1 (en) | 2002-01-18 | 2003-01-17 | Methods of isolating specific cells of caenorhabditis elegans and obtaining genomic information therefrom |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35022902P | 2002-01-18 | 2002-01-18 | |
US35022802P | 2002-01-18 | 2002-01-18 | |
US60/350.229 | 2002-01-18 | ||
US60/350,228 | 2002-01-18 | ||
US35695202P | 2002-02-14 | 2002-02-14 | |
US60/356,952 | 2002-02-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003062449A2 WO2003062449A2 (fr) | 2003-07-31 |
WO2003062449A3 WO2003062449A3 (fr) | 2004-01-22 |
WO2003062449A9 true WO2003062449A9 (fr) | 2004-03-18 |
Family
ID=27617585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/001632 WO2003062449A2 (fr) | 2002-01-18 | 2003-01-17 | Procedes d'isolement de cellules specifiques de caenorhabditis elegans et d'obtention d'informations genomiques a partir de celles-ci |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003205235A1 (fr) |
WO (1) | WO2003062449A2 (fr) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776746A (en) * | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
-
2003
- 2003-01-17 AU AU2003205235A patent/AU2003205235A1/en not_active Abandoned
- 2003-01-17 WO PCT/US2003/001632 patent/WO2003062449A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003062449A3 (fr) | 2004-01-22 |
AU2003205235A1 (en) | 2003-09-02 |
WO2003062449A2 (fr) | 2003-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cenik et al. | Maternal ribosomes are sufficient for tissue diversification during embryonic development in C. elegans | |
Shatskikh et al. | Functional significance of satellite DNAs: insights from Drosophila | |
Naish et al. | The structure, function, and evolution of plant centromeres | |
US20020150945A1 (en) | Methods for making polynucleotide libraries, polynucleotide arrays, and cell libraries for high-throughput genomics analysis | |
KR101257500B1 (ko) | mRNA 결합 프로브를 사용한 생세포의 선택 및 분리 | |
Burnette et al. | Trans-acting factors required for inclusion of regulated exons in the Ultrabithorax mRNAs of Drosophila melanogaster | |
CN110804628A (zh) | 高特异性无脱靶单碱基基因编辑工具 | |
Yan et al. | Characterization of the Drosophila suzukii β2-tubulin gene and the utilization of its promoter to monitor sex separation and insemination | |
Liang et al. | Discovery and characterization of chromosomal inversions in the arboviral vector mosquito Aedes aegypti | |
Brown | Understanding a genome sequence | |
WO2003062449A9 (fr) | Procedes d'isolement de cellules specifiques de caenorhabditis elegans et d'obtention d'informations genomiques a partir de celles-ci | |
Mohammed et al. | Promoter and piggyBac activities within embryos of the potato tuber moth, Phthorimaea operculella, Zeller (Lepidoptera: Gelechiidae) | |
WO2005079357A9 (fr) | Representations d'acides nucleiques mettant en oeuvre des produits de clivage d'endonucleases de restriction de type iib | |
CN112852872A (zh) | 一种用于直接检测环境雌激素的转基因斑马鱼的构建方法 | |
Betsy et al. | Fisheries biotechnology and bioinformatics | |
Mills et al. | Characterization of early follicular cDNA library suggests evidence for genetic polymorphisms in the inbred strain C108 of Bombyx mori | |
US7354718B2 (en) | Molecular dissection method using trans-splicing to designed spliced leader sequences, genes, and constructs thereof | |
Diener et al. | Optimization of differential display polymerase chain reaction as a bioindicator for the cladoceran Daphnia magna | |
US20090298065A1 (en) | Methods for Identifying Functional Noncoding Sequences | |
Běhálková | Testing the synteny of genes in Yponomeuta evonymella | |
Luviano et al. | Hit-and-Run Epigenetic Editing for Vectors of Snail-Borne Parasitic Diseases | |
Kagan | Maternal gene evolution from a comparative perspective | |
Kuroda | Drosophila tissue culture: Retrospect and prospect | |
Akeju | NOVEL TRANSCRIPTIONAL PROFILING OF CELLS IN THE DROSOPHILA TESTIS | |
Nourie | Analyzing the Regulation of twin of eyeless Expression during Early Drosophila melanogaster Development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1/6-6/6, DRAWINGS, REPLACED BY NEW PAGES 1/8-8/8; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |